MYCN and neuroblastoma: There is an inverse correlation between MYCN expression and that of ligands for NK-cell-activating receptors and MYCN acts as an immunosuppressive oncogene in NB cells because MYCN protein negatively regulates the expression of ligands for the NKG2D and DNAM-1 (aka CD226) receptors that activate NK cells [40].